![Tom Gibbs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Gibbs
Directeur/Bestuurslid bij
BC Platforms AG
Profiel
Dr. Tom Gibbs is a Senior Investment Director at Debiopharm Investment SA. He is on the Board of Directors at BC Platforms AG and Carevive Systems, Inc.
He received his doctorate degree from the University of Warwick.
Actieve functies van Tom Gibbs
| Bedrijven | Functie | Begin |
|---|---|---|
BC Platforms AG
 BC Platforms AG Data Processing ServicesTechnology Services Provides healthcare data management and analytics services | Directeur/Bestuurslid | 01-06-2017 |
Carevive Systems, Inc.
 Carevive Systems, Inc. Packaged SoftwareTechnology Services Develops integrated cancer care management software | Directeur/Bestuurslid | - |
Debiopharm Investment SA
 Debiopharm Investment SA Investment ManagersFinance Debiopharm Investment invests in small and mid-market companies located in Europe. The firm focuses on next gen pharma R&D, clinical trial tech and digital medicine sectors. It provides financing in the form of debt and equity for pre-seed, seed and early stage transactions with an investment size of USD 1 - 5 million. The firm makes co-investments and takes minority interests. It also acts as a lead investor. | Private Equity Investor | - |
Opleiding van Tom Gibbs
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
21
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Debiopharm Investment SA
Debiopharm Investment SA Investment ManagersFinance Debiopharm Investment invests in small and mid-market companies located in Europe. The firm focuses on next gen pharma R&D, clinical trial tech and digital medicine sectors. It provides financing in the form of debt and equity for pre-seed, seed and early stage transactions with an investment size of USD 1 - 5 million. The firm makes co-investments and takes minority interests. It also acts as a lead investor. | Finance |
Carevive Systems, Inc.
Carevive Systems, Inc. Packaged SoftwareTechnology Services Develops integrated cancer care management software | Technology Services |
BC Platforms AG
BC Platforms AG Data Processing ServicesTechnology Services Provides healthcare data management and analytics services | Technology Services |
